Chongqing starts R&D base for precission medicine

The main organizer, Chongqing Precision Biotechnology Co., has signed into cooperation agreements with Universities in Germany and Switzerland to promote individualized medical research and therapy on cancer, autoimmune and metabolic diseases based on molecular biology research.

China Bio news release, October 31, 2016

Chongqing starts R&D base for precission medicine
Scroll to top